SOPHiA GENETICS S.A.
HealthcareNASDAQ:SOPH · NASDAQ Global Select
-$0.32 today
Vol 0.09M · Avg 0.10M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+70.03%
Period High
$5.52
Period Low
$2.87
Latest
$4.88
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Agilon Health, Inc.
NYSE:AGL
$1.88B
Alto Neuroscience, Inc.
NYSE:ANRO
$753.47M
National Research Corporation
NASDAQ:NRC
$423.46M
Simulations Plus, Inc.
NASDAQ:SLP
$329.75M
Cellectis S.A.
NASDAQ:CLLS
$310.29M
Larimar Therapeutics, Inc.
NASDAQ:LRMR
$296.96M
AC Immune S.A.
NASDAQ:ACIU
$235.10M
OptimizeRx Corporation
NASDAQ:OPRX
$98.14M
Definitive Healthcare Corp.
NASDAQ:DH
$88.59M
Nakamoto Inc.
NASDAQ:NAKA
$75.18M
What is the latest SOPH filing?
The latest filing shown is 4 dated Jun 11, 2026.
How many recent filings does SOPH have?
Intrinsic Alpha currently shows 20 recent filings for SOPH.
Explore More
Continue the stock analysis
Jump to another research area for this company.